The new GLP-1 medications are very effective, and they have also made more people in medicine and outside of medicine aware of the harms that obesity can have
Genetic predisposition does not determine your exact response, but it can support a more personalized conversation with your healthcare provider about expected gastrointestinal effects and optimal titration timing
It is not intended for human or animal consumption, medical use, or diagnostic purposes
Retatrutide is an investigational drug not yet approved by the FDA
If appropriate, your provider can prescribe nausea-relief medications like ondansetron and send them directly to your pharmacy
For example, patients with genetic predispositions toward lower NAD+ availability may experience better weight loss sustainability and reduced side effect burden when NAD+ restoration is integrated into their GLP-1 regimen